Fairvalue-Calculator Fairvalue-Calculator
EN DE

Bio-View Ltd (BIOV) Fair Value & Analysis

Healthcare · Il · Market cap 18.3M ILA

Price0.9410 ILA
Fair Value1.92 ILA
Upside+104.0%
Quality95/100
Evidence: Low Range 1.76 ILA – 2.16 ILA

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Bio-View Ltd (BIOV) currently trades at 0.9410 ILA, while our model-based Fair Value estimate is 1.92 ILA — implying the stock looks roughly 104.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company's products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH and Karyotype samples in real-time; and Allegro Plus, an automatic imaging system, which identifies various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. It also offers DUET-3, an automated imaging system that supports multiple applications; Encore, an automated barcode reader, which enables scanning of various test types in a single scan batch; DeNovo, an automated scanning system for detection, analysis, and characterization of circulating tumor cells from peripheral blood;…

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -9% Boston Scientific Corporation (B1SX34) -83% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Bio-View Ltd (BIOV) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 1.92 ILA versus a price of 0.9410 ILA — about +104% (undervalued). Model-based estimate, not financial advice.
What is the fair value of BIOV?
Our 21-model fair value for Bio-View Ltd is 1.92 ILA (as of Jun 25, 2026), built from audited fundamentals. The current price is 0.9410 ILA.
What is the quality score of BIOV?
Bio-View Ltd has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.